HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Gong Selected Research

high iron diamine-alcian blue

2/2006[Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].
10/2005Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Gong Research Topics

Disease

63Neoplasms (Cancer)
06/2022 - 01/2008
15Inflammation (Inflammations)
07/2019 - 09/2006
13Adenocarcinoma
11/2022 - 10/2007
13Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2016
10Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 12/2011
9Hepatocellular Carcinoma (Hepatoma)
06/2022 - 04/2017
9Microsatellite Instability
06/2022 - 01/2017
8Neoplasm Metastasis (Metastasis)
11/2022 - 10/2016
8Stomach Neoplasms (Stomach Cancer)
12/2021 - 02/2006
8Carcinogenesis
01/2021 - 10/2007
7Renal Cell Carcinoma (Grawitz Tumor)
03/2022 - 01/2016
7Prostatic Neoplasms (Prostate Cancer)
03/2021 - 11/2011
7Insulin Resistance
01/2019 - 02/2010
5Non-alcoholic Fatty Liver Disease
11/2018 - 01/2014
5Cardiomegaly (Heart Hypertrophy)
01/2018 - 05/2016
5Metaplasia
12/2010 - 04/2004
4Rectal Neoplasms (Rectal Cancer)
06/2022 - 01/2020
4Turcot syndrome
06/2022 - 01/2019
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 01/2018
4Fatty Liver
01/2019 - 01/2017
4Obesity
11/2018 - 06/2004
4Fibrosis (Cirrhosis)
01/2018 - 10/2002
4Gastroesophageal Reflux (GERD)
12/2010 - 11/2004
3Esophageal Neoplasms (Esophageal Cancer)
02/2022 - 09/2005
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2019
3Liver Diseases (Liver Disease)
01/2019 - 04/2017
3Sarcoma (Soft Tissue Sarcoma)
01/2018 - 09/2013
3Ischemic Stroke
12/2017 - 08/2015
3Atherosclerosis
02/2017 - 01/2017
3Myoma
02/2011 - 07/2008
3Infections
12/2010 - 03/2004
2Pain (Aches)
06/2022 - 07/2019
2Hyperglycemia
06/2022 - 01/2014
2Carcinoma (Carcinomatosis)
06/2022 - 02/2006
2Residual Neoplasm
05/2022 - 09/2021
2COVID-19
01/2021 - 01/2020
2Heart Failure
01/2021 - 01/2018
2Colonic Neoplasms (Colon Cancer)
05/2020 - 01/2019
2Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2019 - 01/2019
2Diabetes Complications
07/2019 - 01/2019
2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 12/2018
2Pancreatitis
12/2018 - 10/2010

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2007
13Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2017
10pembrolizumabIBA
01/2021 - 01/2017
8Immune Checkpoint InhibitorsIBA
03/2022 - 01/2018
6Long Noncoding RNAIBA
06/2022 - 10/2016
6MicroRNAs (MicroRNA)IBA
02/2022 - 01/2014
6Pharmaceutical PreparationsIBA
01/2021 - 08/2015
6B7-H1 AntigenIBA
01/2021 - 01/2018
5Messenger RNA (mRNA)IBA
06/2022 - 01/2004
5AcidsIBA
02/2022 - 11/2004
4Insulin (Novolin)FDA Link
06/2022 - 02/2010
4CateninsIBA
01/2020 - 01/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019 - 01/2016
4LipidsIBA
01/2019 - 01/2016
4TOR Serine-Threonine KinasesIBA
10/2016 - 01/2014
3Circulating Tumor DNAIBA
05/2022 - 01/2019
3NivolumabIBA
05/2020 - 01/2018
3Phosphotransferases (Kinase)IBA
06/2019 - 11/2008
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 01/2014
3Ethanol (Ethyl Alcohol)IBA
01/2019 - 10/2010
3Hormones (Hormone)IBA
04/2018 - 01/2014
2COVID-19 VaccinesIBA
12/2022 - 12/2021
2Programmed Cell Death 1 ReceptorIBA
11/2022 - 10/2018
2Hyaluronic Acid (Hyaluronan)IBA
11/2022 - 01/2022
2Carcinoembryonic AntigenIBA
05/2022 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2017
2RNA (Ribonucleic Acid)IBA
01/2022 - 10/2016
2Arginine (L-Arginine)FDA Link
01/2022 - 07/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2015
2Peptides (Polypeptides)IBA
12/2021 - 04/2017
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
04/2021 - 05/2020
2Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2021 - 01/2019
2olaparibIBA
01/2021 - 01/2019
2Capecitabine (Xeloda)FDA Link
01/2021 - 12/2018
2PlatinumIBA
01/2021 - 01/2019
2Competitive Endogenous RNAIBA
01/2021 - 08/2019
2AndrogensIBA
12/2020 - 01/2020
2Androgen Receptors (Androgen Receptor)IBA
12/2020 - 01/2020
2IpilimumabIBA
05/2020 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
05/2020 - 10/2016
2Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 01/2017
2Circular RNAIBA
08/2019 - 07/2018
2Lysine (L-Lysine)FDA Link
07/2019 - 10/2016
2Advanced Glycation End ProductsIBA
07/2019 - 01/2019
2Pyruvaldehyde (Methylglyoxal)IBA
07/2019 - 01/2019
2Biological ProductsIBA
01/2019 - 09/2015
2BilirubinIBA
01/2019 - 04/2002
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2019 - 03/2017
2Antineoplastic Agents (Antineoplastics)IBA
04/2018 - 01/2014

Therapy/Procedure

43Therapeutics
11/2022 - 07/2009
20Drug Therapy (Chemotherapy)
06/2022 - 09/2013
17Immunotherapy
06/2022 - 01/2018
6Radiotherapy
12/2021 - 03/2015
4Neoadjuvant Therapy
01/2022 - 01/2018
3Adjuvant Chemotherapy
05/2022 - 01/2017
3Pancreaticoduodenectomy
04/2021 - 01/2012
3Castration
01/2021 - 11/2011
2Palliative Care (Palliative Therapy)
09/2020 - 01/2020